Brooke Story
Director, Sigilon Therapeutics, Inc.
Companies
- PolyPid Ltd.Board member Mar 18, 2026 to now1
- LivaNovaBoard member Sep 19, 2022 to now2
- Sigilon Therapeutics, Inc.Board member Jun 16, 2021 to May 27, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 4, 2026Sold 2,300 shares at $81.42 of LivaNova4
- Jun 15, 2026Shares withheld for tax 486 shares at $79.70 of LivaNova5
- Jun 15, 2026Exercised options 4,042 shares of LivaNova5
- Nov 18, 2025Sold 250 shares at $53.94 of LivaNova6
- Jun 15, 2025Shares withheld for tax 410 shares at $45.76 of LivaNova7
- Jun 15, 2025Exercised options 3,416 shares of LivaNova7
- Jun 15, 2024Shares withheld for tax 584 shares at $52.68 of LivaNova8
- Jun 15, 2024Exercised options 2,680 shares of LivaNova8
- Sep 15, 2023Shares withheld for tax 345 shares at $57.80 of LivaNova9
- Sep 15, 2023Exercised options 1,725 shares of LivaNova9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPolyPid Ltd., Board member
- 2SEC EDGARLivaNova, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 17, 2026
- 6SEC EDGARForm 4 filed Nov 19, 2025
- 7SEC EDGARForm 4 filed Jun 17, 2025
- 8SEC EDGARForm 4 filed Jun 18, 2024
- 9SEC EDGARForm 4 filed Sep 19, 2023